Camitotic

Medicinal product

(Invented) name

Camitotic

Active substance (s)

Docetakselis

Strength

20 mg/ml

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01CD02, Docetaxel

Marketing authorisation holder

Teva B.V., Nyderlandai

Date of authorisation

2010-12-15

Date of renewal

2016-06-08

Documents

2263 Pakuotės lapelis 2023 10 23.docx

2263 Camitotic PCS PL 2023 10 23.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(3)

Procedure number

LV/H/0214/001

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

1 ml koncentrato yra	1 ml
Docetakselis	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
35520	37853	1037853	flakonas	1 ml N1		Receptinis	LT/1/10/2263/001	Netiekiama	-	-	No	-	-	Download
35521	37854	1037854	flakonas	4 ml N1		Receptinis	LT/1/10/2263/002	Netiekiama	-	-	No	-	-	Download
35522	37855	1037855	flakonas	7 ml N1		Receptinis	LT/1/10/2263/003	Netiekiama	-	-	No	-	-
97390	81940	1081940	flakonas	8 ml N1		Receptinis	LT/1/10/2263/004	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-02-27	Išregistruotas
2016-06-08	Perregistruotas
2010-12-15	Registruotas